FDA approves Aricept 23 mg tablet for Alzheimer's disease
Links shared publicly online about this topic.
- 995total visits
FDA approves Aricept 23 mg tablet for Alzheimer's disease
View full resource at news-medical.net
Tags: Alzheimer's Disease, Alzheimer's Disease Medication, Disease and Condition, FDA, Aricept, Pfizer, Eisai, Oncology
Most Recently Shared on July 26, 2010 at 6:48 am By:
Oncology News: FDA approves Aricept 23 mg tablet for Alzheimer's disease: Eisai Inc. and Pfizer Inc announced toda... http://bit.ly/bUsCXG
Eisai Announces U.S. Fda Approval For New Higher Dose Aricept® 23 Mg Tablet For The Treatment Of Moderate-To-Severe Alzheimer's Disease
medicalnewstoday.com — “Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito) announced that its U.S. subsidiary Eisai Inc. has received approval from the U.S. Food and Drug Administration (FDA) for Aricept” View full resource at medicalnewstoday.com
Most Recently Shared on July 31, 2010 at 2:05 pm By:
MNT Alzheimer's News Health News
Eisai Announces U.S. Fda Approval For New Higher Dose Aricept® 23 Mg Tablet For The Treatment Of Moderate-To-Sever... http://mnt.to/3GPp
Eisai Inc. and Pfizer Inc Announce U.S. FDA Approval for New Higher-Dose Aricept (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer's Disease
drugs.com — “Aricept (donepezil) is used to treat Alzheimer's disease. Includes Aricept side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 27, 2010 at 2:15 am By:
FDA Approves Higher-Dose Aricept (donepezil) 23 mg for the Treatment of Alzheimer's Disease - http://bit.ly/9TBLyE
Medical News: Higher-Strength Donepezil Pill Wins FDA Nod - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “A new dosing recommendation follows the FDA's approval of the anti-dementia drug donepezil (Aricept) in a 23-mg tablet for use in patients with moderate to severe Alzheimer's disease.” View full resource at medpagetoday.com
Most Recently Shared on July 26, 2010 at 5:10 pm By:
Patricia Grace Eldercare Expert
Higher-Strength Donepezil Pill Wins FDA Nod: A new dosing recommendation follows the FDA's approval of the anti-de... http://bit.ly/9leaY2
Medical News: Higher-Strength Donepezil Pill Wins FDA Nod - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “A new dosing recommendation follows the FDA's approval of the anti-dementia drug donepezil (Aricept) in a 23-mg tablet for use in patients with moderate to severe Alzheimer's disease.” View full resource at medpagetoday.com
Most Recently Shared on July 26, 2010 at 4:37 pm By:
Higher-Strength Donepezil Pill Wins FDA Nod A new dosing recommendation follows the FDA's approval of the anti-dementia.. http://dld.bz/nKYh
Aricept 23mg approved for Alzheimer's disease - MPR
empr.com — “The FDA has approved Eisai's Aricept (donepezil HCl tablets) in a 23mg dosage strenghth for the treatment of moderate-to-severe Alzheimer's disease.” View full resource at empr.com
Most Recently Shared on July 26, 2010 at 3:06 pm By:
MPR News: Aricept 23mg approved for Alzheimer's disease: The FDA has approved Eisai's Aricept (donepezil HCl table... http://bit.ly/b1hMsu
Aricept 23mg approved for Alzheimer's disease - ONA
oncologynurseadvisor.com — “The FDA has approved Eisai--™s Aricept (donepezil HCl tablets) in a 23mg dosage strength for the treatment of moderate-to-severe Alzheimer--™s disease.” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 26, 2010 at 3:03 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Aricept 23mg approved for Alzheimer's disease http://goo.gl/fb/Ifolw
FDA accepts NDA for extended release Aricept, a treatment for Alzheimer's disease (AD) - MPR
empr.com — “Eisai and Pfizer announced that the FDA has accepted for review the New Drug Application (NDA) for once-daily 23 mg Aricept (donepezil HCl extended release tablets) for the treatment of moderate to severe Alzheimer's disease (AD).” View full resource at empr.com
Most Recently Shared on November 25, 2009 at 3:51 pm By:
MPR News: FDA accepts NDA for extended release Aricept, a treatment for Alzheimer's disease (AD): Eisai and Pfizer ... http://bit.ly/6GSvRg
Advertisement
